Minami Takuya, Wampold Bruce E, Serlin Ronald C, Kircher John C, Brown George S Jeb
Department of Educational Psychology, University of Utah, Salt Lake City, UT 84112, USA.
J Consult Clin Psychol. 2007 Apr;75(2):232-43. doi: 10.1037/0022-006X.75.2.232.
This study estimates pretreatment-posttreatment effect size benchmarks for the treatment of major depression in adults that may be useful in evaluating psychotherapy effectiveness in clinical practice. Treatment efficacy benchmarks for major depression were derived for 3 different types of outcome measures: the Hamilton Rating Scale for Depression (M. A. Hamilton, 1960, 1967), the Beck Depression Inventory (A. T. Beck, 1978; A. T. Beck & R. A. Steer, 1987), and an aggregation of low reactivity-low specificity measures. These benchmarks were further refined for 3 conditions: treatment completers, intent-to-treat samples, and natural history (wait-list) conditions. The study confirmed significant effects of outcome measure reactivity and specificity on the pretreatment-posttreatment effect sizes. The authors provide practical guidance in using these benchmarks to assess treatment effectiveness in clinical settings.
本研究估算了成人重度抑郁症治疗前后的效应量基准，这可能有助于在临床实践中评估心理治疗的效果。针对3种不同类型的结果测量指标得出了重度抑郁症的治疗效果基准：汉密尔顿抑郁评定量表（M. A. 汉密尔顿，1960年，1967年）、贝克抑郁量表（A. T. 贝克，1978年；A. T. 贝克和R. A. 斯特尔，1987年），以及低反应性-低特异性测量指标的汇总。这些基准针对3种情况进一步细化：治疗完成者、意向性治疗样本和自然病程（等待名单）情况。该研究证实了结果测量指标的反应性和特异性对治疗前后效应量有显著影响。作者提供了在临床环境中使用这些基准评估治疗效果的实用指导。
